Xenon Pharmaceuticals Inc. — Director's Dealing 2015

Jan 7, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Xenon Pharmaceuticals Inc. (XENE)
CIK: 0001582313
Period of Report: 2014-12-31

Reporting Person: MX Associates, LLP (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-12-31	Common Shares	J	1169286	—	Disposed	305374	Direct
2014-12-31	Common Shares	J	117456	—	Disposed	187918	Direct
2014-12-31	Common Shares	J	85119	—	Disposed	102799	Direct
2014-12-31	Common Shares	J	85119	—	Disposed	17680	Direct
2014-12-31	Common Shares	J	17680	—	Disposed	0	Direct

Footnotes

F1: Transactions representing a distribution in kind of shares resulting from the dissolution of the Reporting Person.